Hepion Pharmaceuticals, Inc. (HEPA) › Total LiabilitiesHepion Pharmaceuticals, Inc. (HEPA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $227.2K2014: $4.93M2015: $1.94M2016: $11.79M2017: $7.55M2018: $6.21M2019: $4.99M2020: $8.12M2021: $10.56M2022: $10.39M2023: $10.81M2024: $3.48M2025: $402.4K$402.4K2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$402.4K-88.4%2024$3.48M-67.8%2023$10.81M+4.1%2022$10.39M-1.6%2021$10.56M+29.9%2020$8.12M+62.7%2019$4.99M-19.6%2018$6.21M-17.7%2017$7.55M-36.0%2016$11.79M+508.3%2015$1.94M-60.7%2014$4.93M+2071.6%2013$227.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share